Download Files:
Products Details
Product Description
– NXT-10796 is orally active, intestinally restricted EP4 receptor agonist[1].
Web ID
– HY-155321
Shipping
– Room temperature
Molecular Formula
– C23H31N3O6
References
– [1]St-Onge M, et al. Discovery of NXT-10796, an orally active, intestinally restricted EP4 agonist prodrug for the treatment of inflammatory bowel disease. Bioorg Med Chem Lett. 2023;91:129351.
Molecular Weight
– 445.51
SMILES
– O=C(NNC(C(O)=O)=O)CCCCCCN1[C@@H](/C=C/[C@@H](O)CC2=CC=CC=C2)CCC1=O
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Prostaglandin Receptor
Pathway
– GPCR/G Protein
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
